Lawrence Guiheen

Lawrence Guiheen

Direttore/Membro del Consiglio presso ADMA BIOLOGICS, INC.

Patrimonio netto: 1 M $ in data 31/07/2026

75 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Lawrence P.
Guiheen
is an Independent Director at ADMA Biologics, Inc. since 2012 and a Director at Kedrion Biopharma, Inc. since 2019.
Former roles include Chief Executive Officer at Wellmond Therapeutics from 2019 to 2022, Executive Vice President at Wellstat Management Co. LLC from 2019 to 2022, General Manager-Global Hemophilia Franchise at Baxter Healthcare Corp.
from 2010 to 2011, President-BioPharmaceuticals at Baxter BioScience Corp.
from 2010 to 2011, Principal at Guiheen & Associates LLC from 2011 to 2013, Chairman at Plasma Protein Therapeutics Association, and Director at California Healthcare Institute.
Education includes undergraduate studies at Rutgers State University of New Jersey.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
31/03/2026 175.820 ( 0,08% ) 1 M $ 31/07/2026

Posizioni attive di Lawrence Guiheen

SocietàPosizioneInizio
ADMA BIOLOGICS, INC. Direttore/Membro del Consiglio 24/07/2012
Direttore/Membro del Consiglio 01/11/2019

Precedenti posizioni note di Lawrence Guiheen

SocietàPosizioneFine
Wellmond Therapeutics
Amministratore Delegato 01/02/2022
Corporate Officer/Principal 01/02/2022
Guiheen & Associates LLC
Corporate Officer/Principal 01/07/2013
Corporate Officer/Principal -
Corporate Officer/Principal 01/07/2011
Vedi nel dettaglio l'esperienza di Lawrence Guiheen

Formazione di Lawrence Guiheen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

69

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Guiheen & Associates LLC

Health Services

Wellmond Therapeutics

  1. Mercati
  2. Insiders
  3. Lawrence Guiheen